XML 15 R6.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Cash flows from operating activities:    
Net (loss) income $ (11,209) $ 35,114
Adjustments to reconcile net (loss) income to net cash (used in)/provided by operations:    
Depreciation and amortization 3,312 3,455
Stock-based compensation expense 1,236 2,402
Provision for excess and obsolete inventory 491 686
Gain on sale of minority interest 0 (127)
Deferred income taxes (1,069) (940)
Change in fair value of warrants (4,648) 2,658
Non-cash interest income 0 (168)
Other non-cash items (22) (752)
Unrealized foreign exchange (gain)/loss on cash and cash equivalents (209)
Changes in operating asset and liability accounts:    
Accounts receivable (8,661) (724)
Inventory (6,968) 3,320
Prepaid expenses and other assets (332) (1,380)
Accounts payable and accrued expenses 2,648 4,603
Deferred revenue 7,652 (361)
Net cash (used in)/provided by operating activities (17,779) 47,786
Cash flows from investing activities:    
Purchase of property, plant and equipment (2,926) (709)
Proceeds from the sale of property, plant and equipment 3,001 138
Purchase of marketable securities (35,000)
Proceeds from sale of minority interest 0 127
Change in other assets 37 (206)
Net cash used in investing activities (34,888) (650)
Cash flows from financing activities:    
Employee taxes paid related to net settlement of equity awards (565) (456)
Proceeds from exercise of warrants 6,139
Proceeds from exercise of employee stock options and ESPP 100 71
Net cash (used in)/provided by financing activities 5,674 (385)
Effect of exchange rate changes on cash 30 (792)
Net (decrease)/increase in cash, cash equivalents and restricted cash (46,963) 45,959
Cash, cash equivalents and restricted cash at beginning of period 78,198 34,248
Cash, cash equivalents and restricted cash at end of period 31,235 80,207
Supplemental schedule of cash flow information:    
Cash paid for income taxes, net of refunds 3,520 2,792
Issuance of common stock to settle liabilities 242 235
Hercules [Member]    
Supplemental schedule of cash flow information:    
Issuance of common stock to Hercules to settle warrant liability $ 294 $ 0